1. Home
  2. IMCR vs ENR Comparison

IMCR vs ENR Comparison

Compare IMCR & ENR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMCR
  • ENR
  • Stock Information
  • Founded
  • IMCR 2008
  • ENR 2015
  • Country
  • IMCR United Kingdom
  • ENR United States
  • Employees
  • IMCR N/A
  • ENR N/A
  • Industry
  • IMCR Biotechnology: Biological Products (No Diagnostic Substances)
  • ENR Industrial Machinery/Components
  • Sector
  • IMCR Health Care
  • ENR Miscellaneous
  • Exchange
  • IMCR Nasdaq
  • ENR Nasdaq
  • Market Cap
  • IMCR 1.5B
  • ENR 1.5B
  • IPO Year
  • IMCR 2021
  • ENR N/A
  • Fundamental
  • Price
  • IMCR $32.80
  • ENR $21.51
  • Analyst Decision
  • IMCR Buy
  • ENR Hold
  • Analyst Count
  • IMCR 10
  • ENR 8
  • Target Price
  • IMCR $58.13
  • ENR $31.63
  • AVG Volume (30 Days)
  • IMCR 444.9K
  • ENR 1.1M
  • Earning Date
  • IMCR 08-07-2025
  • ENR 08-05-2025
  • Dividend Yield
  • IMCR N/A
  • ENR 5.58%
  • EPS Growth
  • IMCR N/A
  • ENR N/A
  • EPS
  • IMCR N/A
  • ENR 0.74
  • Revenue
  • IMCR $333,581,000.00
  • ENR $2,901,700,000.00
  • Revenue This Year
  • IMCR $26.82
  • ENR $1.77
  • Revenue Next Year
  • IMCR $8.15
  • ENR $1.63
  • P/E Ratio
  • IMCR N/A
  • ENR $28.96
  • Revenue Growth
  • IMCR 25.75
  • ENR 0.39
  • 52 Week Low
  • IMCR $23.15
  • ENR $19.70
  • 52 Week High
  • IMCR $41.54
  • ENR $39.52
  • Technical
  • Relative Strength Index (RSI)
  • IMCR 51.47
  • ENR 49.84
  • Support Level
  • IMCR $30.76
  • ENR $19.78
  • Resistance Level
  • IMCR $33.95
  • ENR $20.66
  • Average True Range (ATR)
  • IMCR 1.39
  • ENR 0.60
  • MACD
  • IMCR -0.15
  • ENR 0.26
  • Stochastic Oscillator
  • IMCR 43.05
  • ENR 82.09

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

About ENR Energizer Holdings Inc.

Energizer Holdings Inc makes and distributes household batteries, specialty batteries, and lighting products. Energizer offers batteries using lithium, alkaline, carbon-zinc, nickel-metal hydride, zinc-air, and silver oxide technologies. These products are sold under the Energizer, Rayovac, Varta and Eveready brands at performance and premium price segments. It also offers auto care products in the appearance, fragrance, performance, and air conditioning recharge product categories. The company operates in two geographical segments: Americas and International, of which the majority of its revenue is derived from the America. It has two product segments: Batteries & Lights and Auto Care. It earns maximum revenue from Batteries & Lights segment.

Share on Social Networks: